Pill that could protect from nuclear fallout
Humanetics have been cleared to start human clinical testing of a new drug that could provide protection from the effects of nuclear fallout.
Humanetics have been cleared to start human clinical testing of a new drug that could provide protection from the effects of nuclear fallout.
A new radio frequency identification (RFID) chip has been developed by Pliant and IBM that can not only track drug products through the supply chain but also identify when a product has been tampered with.
Giant drug manufacturer Eli Lilly last week announced a reshuffle in its global manufacturing operations to reflect the company's focus on its current product portfolio and drug pipeline.
Scientists are developing a new obesity drug inspired by a natural hormone in the gut that tells our bodies when we are full.
Canadian firm SemBioSys Genetics last week announced that its proprietary plant-produced insulin has been shown to be indistinguishable from human insulin, opening up a whole new potential source of the hormone.
GrapeCity has joined Microsoft's BioIT Alliance, a collaboration between the pharmaceutical and computer industries aimed at helping make the vision of personalised medicine a reality.
Aspectric's industrial infrared spectroscopy analyser, recently launched into a market valued at $1.6 billion, has been granted a new US patent.
UK-based company ProMinent Fluid Controls has launched an on-line sensor targeting the regulation of peracetic acid, a key disinfectant used in the pharmaceutical industry.
Recent trial results have indicated a link between low LDL-cholesterol levels and Parkinson's disease, especially if the low levels are naturally occurring.
A high throughput microfluidic platform brings the ability to understand biological network function a step closer.